PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice

@inproceedings{Arsenyeva2013PReSFINAL2061AI,
  title={PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice},
  author={SV Arsenyeva and I P Nikishina and MI Kaleda and D A Alekseev and LG Medyntceva and SR Rodionovskaya},
  year={2013}
}
Methods The analysis includes data of 60 patients with JIA who were getting ABA in 2010 2013. The average age of patients is 12,5 years (from 6 to 18 years). 21 (35%) patients suffered from active uveitis (2 patients had one eye affection, 19 had affection of both eyes). 10 (16%) patients were diagnosed as sJIA without current systemic features. Patients… CONTINUE READING